X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (447) 447
Conference Proceeding (18) 18
Book Review (10) 10
Patent (10) 10
Publication (9) 9
Magazine Article (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Streaming Audio (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (194) 194
index medicus (170) 170
male (159) 159
endokrinologi och diabetes (153) 153
endocrinology and diabetes (152) 152
medical and health sciences (151) 151
medicin och hälsovetenskap (151) 151
female (143) 143
middle aged (137) 137
adult (109) 109
diabetes mellitus (108) 108
risk factors (107) 107
aged (96) 96
diabetes (92) 92
endocrinology & metabolism (90) 90
clinical medicine (85) 85
klinisk medicin (77) 77
mortality (64) 64
type 2 diabetes (63) 63
registries (61) 61
sweden (55) 55
cardiovascular diseases (52) 52
insulin (51) 51
mellitus (50) 50
sweden - epidemiology (48) 48
medicine (44) 44
cardiovascular disease (42) 42
complications (39) 39
diabetes mellitus, type 2 - complications (37) 37
myocardial-infarction (37) 37
obesity (37) 37
body mass index (36) 36
medicin (34) 34
risk (34) 34
epidemiology (33) 33
blood pressure (32) 32
type 2 (32) 32
analysis (31) 31
research (31) 31
diabetes mellitus, type 2 - drug therapy (30) 30
insulin resistance (29) 29
drug therapy (28) 28
proportional hazards models (27) 27
stroke (27) 27
blood (26) 26
cardiovascular-disease (26) 26
glucose (26) 26
cardiac and cardiovascular systems (25) 25
kardiologi (25) 25
medicine, general & internal (25) 25
diabetes mellitus, type 2 - epidemiology (24) 24
disease (24) 24
health risk assessment (24) 24
internal medicine (24) 24
metabolism (24) 24
patients (24) 24
peripheral vascular disease (24) 24
diabetes mellitus, type 2 - blood (23) 23
blood glucose - metabolism (22) 22
cholesterol (22) 22
hypertension (22) 22
myocardial infarction (22) 22
studies (22) 22
cardiovascular diseases - etiology (21) 21
follow-up studies (21) 21
glycemic control (21) 21
hypoglycemic agents - therapeutic use (21) 21
treatment outcome (21) 21
association (20) 20
care and treatment (20) 20
diabetes mellitus, type 2 - physiopathology (20) 20
hemoglobin a (20) 20
regression analysis (20) 20
cross-sectional studies (19) 19
health aspects (19) 19
hypoglycemic agents (19) 19
outcomes (19) 19
register (19) 19
risk-factors (19) 19
time factors (19) 19
cardiovascular diseases - epidemiology (18) 18
cardiovascular diseases - mortality (18) 18
cohort studies (18) 18
glycated hemoglobin a - metabolism (18) 18
type 1 diabetes (18) 18
abridged index medicus (17) 17
coronary-heart-disease (17) 17
metaanalysis (17) 17
therapy (17) 17
insulin-resistance (16) 16
longitudinal studies (16) 16
medical research (16) 16
prevalence (16) 16
prognosis (16) 16
therapeutic use (16) 16
young adult (16) 16
aged, 80 and over (15) 15
cardiac & cardiovascular systems (15) 15
hyperglycemia (15) 15
lipids (15) 15
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (432) 432
Swedish (36) 36
Chinese (3) 3
French (2) 2
German (2) 2
Danish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 16, pp. 1644 - 1652
Journal Article
BMJ : British Medical Journal, ISSN 0959-8138, 6/2015, Volume 350, Issue jun22 1, pp. h3234 - h3234
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 7, pp. 633 - 644
In an observational study, patients with type 2 diabetes who had glycated hemoglobin, LDL cholesterol, albuminuria, and blood pressure in target ranges and did... 
MEDICINE, GENERAL & INTERNAL | GLYCEMIA | HYPERGLYCEMIA | MANAGEMENT | DISEASE | MULTIFACTORIAL INTERVENTION | MICROVASCULAR OUTCOMES | FOLLOW-UP | COMPLICATIONS | MELLITUS | ASSOCIATION | Body Mass Index | Glycated Hemoglobin A - analysis | Albuminuria - complications | Cardiovascular Diseases - etiology | Myocardial Infarction - epidemiology | Humans | Middle Aged | Risk Factors | Male | Sweden - epidemiology | Diabetes Mellitus, Type 2 - blood | Smoking - epidemiology | Diabetes Mellitus, Type 2 - mortality | Cardiovascular Diseases - epidemiology | Hypertension - complications | Adult | Female | Hypercholesterolemia - complications | Stroke - epidemiology | Diabetes Mellitus, Type 2 - complications | Cohort Studies | Diabetics | Cardiovascular diseases | Health aspects | Patient outcomes | Risk factors | Myocardial infarction | Cardiac arrhythmia | Heart attacks | Cardiovascular disease | Confidence intervals | Smoking cessation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Heart diseases | Age | Heart failure | Cerebral infarction | Stroke | Mortality | Diabetes mellitus | Patients | Low density lipoprotein | Cholesterol | Death | Diabetes | Health risk assessment | Smoking | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Klinisk medicin | Medicin och hälsovetenskap | Endocrinology and Diabetes
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 15, pp. 1407 - 1418
Patients with type 1 or type 2 diabetes in Sweden were studied to examine trends in mortality and cardiovascular disease incidence between 1998 and 2014. Both... 
POPULATION | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | HEART-FAILURE | MULTIFACTORIAL INTERVENTION | COMPLICATIONS | PEOPLE | TRENDS | ASSOCIATION | BLOOD-PRESSURE | Cardiovascular Diseases - etiology | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Mortality - trends | Diabetes Mellitus, Type 1 - complications | Sweden - epidemiology | Incidence | Diabetes Mellitus, Type 1 - mortality | Diabetes Mellitus, Type 2 - mortality | Hospitalization - trends | Adolescent | Age of Onset | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Adult | Female | Registries | Aged | Diabetes Mellitus, Type 2 - complications | Complications and side effects | Usage | Mortality | Analysis | Distribution | Event history analysis | Diabetes | Cardiovascular diseases | Heart failure | Heart attacks | Diabetes mellitus | Cardiovascular disease | Diabetes mellitus (insulin dependent) | Metabolism | Patients | Coronary artery disease | Studies | Insulin resistance | Death | Trends | Diabetes mellitus (non-insulin dependent) | Heart diseases | Age | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Kardiologi | epidemiology | Sweden | Endokrinologi och diabetes | Type 2 | trends | Endocrinology and Diabetes | Type 1 | complications | Hospitalization | Diabetes Mellitus | etiology | Cardiac and Cardiovascular Systems | mortality
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2016, Volume 18, Issue 10, pp. 990 - 998
Aim: To investigate the relative safety of various glucose-lowering agents as add-on medication to metformin in type 2 diabetes in an observational study... 
metformin | type 2 diabetes | cardiovascular complications | glucose‐lowering agents | pharmacoepidemiology | glucose-lowering agents | EUROPEAN-ASSOCIATION | MANAGEMENT | EVENTS | PROPENSITY SCORE | COMBINATION THERAPY | INSULIN | PIOGLITAZONE | HYPERGLYCEMIA | SULFONYLUREAS | DISEASE | ENDOCRINOLOGY & METABOLISM | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Humans | Middle Aged | Cardiotoxicity - epidemiology | Coronary Disease - epidemiology | Male | Thiazolidinediones - administration & dosage | Coronary Disease - mortality | Metformin - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Drug Therapy, Combination - adverse effects | Hypoglycemic Agents - administration & dosage | Glucagon-Like Peptide 1 - agonists | Registries - statistics & numerical data | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Sulfonylurea Compounds - administration & dosage | Metformin - administration & dosage | Heart Failure - epidemiology | Heart Failure - mortality | Coronary Disease - chemically induced | Insulin - administration & dosage | Treatment Outcome | Sulfonylurea Compounds - adverse effects | Sweden - epidemiology | Thiazolidinediones - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - mortality | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Heart Failure - chemically induced | Heart failure | Type 2 diabetes | Analysis | Mortality | Glycosylated hemoglobin | Hypoglycemic agents | Glucose | Drug therapy | Health aspects | Coronary heart disease | Dextrose | Diabetes therapy | Confidence intervals | Cardiovascular disease | Diabetes | Health risk assessment | Insulin | Index Medicus | Clinical Medicine | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 07/2010, Volume 33, Issue 7, pp. 1640 - 1646
Journal Article
Diabetologia, ISSN 0012-186X, 10/2015, Volume 58, Issue 10, pp. 2259 - 2268
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 5, pp. 535 - 543
Journal Article